Litcius/Paper detail

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy

Molly M. Daughety, Andrew Morgan, Erin Frost, Chester Kao, Joyce K. Hwang, R. F. Tobin, Bhavik Patel, Matthew Fuller, Ian J. Welsby, Thomas L. Ortel

2020Thrombosis Research38 citationsDOIOpen Access PDF

Topics & Concepts

CoagulopathyMedicineCase fatality rateCoronavirus disease 2019 (COVID-19)ThrombosisCoronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Mortality rateInternal medicineIntensive care medicineDiseaseEpidemiologyVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsLong-Term Effects of COVID-19
COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy | Litcius